openPR Logo
Press release

Somatostatin Analogs Market Poised for 7 % Growth, Set to Hit $9.48 Billion by 2029

03-03-2025 12:15 PM CET | Health & Medicine

Press release from: The Business Research Company

Somatostatin Analogs Global Market Share

Somatostatin Analogs Global Market Share

Which drivers are expected to have the greatest impact on the over the somatostatin analogs market's growth?
The surge in neuroendocrine tumor cases is likely to drive the expansion of the somatostatin analogs market. Neuroendocrine tumors are cancers that originate from specialized neuroendocrine cells. Somatostatin analogs have the property of inhibiting the excess production of hormones thereby controlling the growth of neuroendocrine tumors and minimizing the symptoms of carcinoid diseases. For example, according to Cancer Australia, a national government agency in Australia, about 5,437 fresh cases of neuroendocrine tumors were identified in 2022. It has also estimated that one in every 55 people runs the risk of being diagnosed with neuroendocrine tumors by the time they reach 85. Thus, the increasing prevalence of neuroendocrine tumors is bolstering the growth of the somatostatin analogs market.

Get Your Somatostatin Analogs Market Report Here:
https://www.thebusinessresearchcompany.com/report/somatostatin-analogs-global-market-report

What is the future CAGR of the somatostatin analogs market, and how will it impact industry expansion?
In recent years, the somatostatin analogs market has shown significant growth. Its size is projected to increase from $6.73 billion in 2024 to $7.18 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. This robust growth during the historical period is due to several factors including a rise in net incidence, advancements in the field of oncology research, proven effectiveness in symptom management, widened indications, and patient inclination towards long-acting formulations.

In the coming years, the somatostatin analogs market is projected to experience substantial growth, expanding to a value of $9.48 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. The expected surge during this prediction period can be credited to several factors such as a persistent increase in net incidence, a concentrated research on rare diseases, the progression of combination therapies, advancements in personalized medicine, and global health endeavors in cancer treatment. Key trends forecasted for this period incorporate a growing global elderly population, enhancements in healthcare infrastructure in developing markets, strategic alliances and partnerships, pricing pressures and reimbursement hurdles, as well as the integration of technology in healthcare.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10840&type=smp

What are the most significant trends transforming the somatostatin analogs market today?
The key players in the somatostatin analogs market are concentrating on the creation of innovative products like targeted radiopharmaceuticals to improve the accuracy and efficacy of cancer treatments, particularly for patients with somatostatin receptor-positive tumors. Focused radiopharmaceuticals are drugs that link radiation-emitting isotopes to molecules created to adhere directly to cancer cells, thus ensuring a precise delivery of therapeutic radiation to tumour locations and reducing the impact on healthy tissue surrounding it. For example, in January 2024, Lantheus, a company specializing in radiopharmaceuticals based in the US, released Lutetium Lu 177 Dotatate, a radiolabeled somatostatin analog used in peptide receptor radionuclide therapy (PRRT) for the treatment of advanced somatostatin receptor-positive neuroendocrine tumors. Clinical trials have shown that it is more beneficial in improving progression-free survival and response rates in comparison to traditional somatostatin analogs such as octreotide. It serves as an essential choice for patients whose condition has advanced despite previous treatments. This targeted method enables effective tumor control while reducing systemic exposure, thereby enhancing the comprehensive therapeutic profile in the handling of neuroendocrine malignancies.

Which key market segments comprise the somatostatin analogs market and drive its revenue growth?
The somatostatin analogs market covered in this report is segmented -

1) By Type: Octreotide, Lanreotide, Pasireotide
2) By Treatment: Acromegaly, Cushing's Syndrome, Neuroendocrine Tumors, Carcinoid Syndrome, Other Treatments
3) By End User: Hospital, Pharmaceutical Companies

Subsegments:
1) By Octreotide: Long-Acting Release (LAR) Formulations, Short-Acting Formulations
2) By Lanreotide: Depot Formulations, Injectable Formulations
3) By Pasireotide: Long-Acting Injectable Formulations, Subcutaneous Formulations

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10840

What regions are at the forefront of somatostatin analogs market expansion?
North America was the largest region in the global somatostatin analogs treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatostatin analogs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the somatostatin analogs market?
Major companies operating in the somatostatin analogs market include Novartis International AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Midatech Pharma plc, Crinetics Pharmaceuticals Inc., Peptron Inc., Teva Pharmaceutical Industries Ltd., Camurus AB, Bayer Aktiengesellschaft, Cadila Healthcare Limited, Amneal Pharmaceuticals Inc., Recordati S.p.A., Amryt Pharma plc, Ipsen Pharma SA, Fresenius Kabi AG, Chiasma Inc., Merck KGaA, Sanofi S.A., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Viatris Inc., AstraZeneca plc, Johnson & Johnson, Genentech Inc., OctreoPharm Sciences GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10840&type=smp

What Is Covered In The Somatostatin Analogs Global Market Report?

• Market Size Forecast: Examine the somatostatin analogs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the somatostatin analogs market for a structured understanding.
• Key Players Overview: Analyze major players in the somatostatin analogs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the somatostatin analogs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the somatostatin analogs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the somatostatin analogs market.
• Industry Challenges: Identify potential risks and obstacles affecting the somatostatin analogs market.
• Competitive Landscape: Review strategic developments in the somatostatin analogs market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Somatostatin Analogs Market Poised for 7 % Growth, Set to Hit $9.48 Billion by 2029 here

News-ID: 3894448 • Views:

More Releases from The Business Research Company

Strategic Forecast for the Commercial Real Estate Industry: Market Outlook 2025-2034
Strategic Forecast for the Commercial Real Estate Industry: Market Outlook 2025- …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Commercial Real Estate Market Size Growth Forecast: What to Expect by 2025? The size of the commercial real estate market has significantly expanded over the past few years. The market, which is expected to increase from $5,935.22 billion in 2024 to $6,281.58 billion in 2025, will experience a compound
The Rise Of Coffee Consumption Is Fueling The Growth Of The Market Due To Its Increasing Role In Daily Wellness And Lifestyle Habits: Pivotal Factor Influencing Coffee Shops Market Growth in 2025
The Rise Of Coffee Consumption Is Fueling The Growth Of The Market Due To Its In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Coffee Shops Market Size Growth Forecast: What to Expect by 2025? The size of the coffee shop market has seen robust growth in the past few years. The market, which is projected to be at $83.27 billion in 2024, is expected to reach $89.17 billion by 2025 with a
Driving Chimney Waterproofing Services Market Growth in 2025: The Role of Rising Home Renovation Activities Drive The Market Growth Due To Increasing Home Equity And Demand For Personalized Living Spaces
Driving Chimney Waterproofing Services Market Growth in 2025: The Role of Rising …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Chimney Waterproofing Services Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a substantial growth in the market size for chimney waterproofing services. The market is projected to expand from $1.53 billion in 2024 to $1.67 billion in 2025, demonstrating a compound annual
Emerging Trends to Drive Ceramic Coated Separators Market Growth at 20.9% CAGR Through 2029
Emerging Trends to Drive Ceramic Coated Separators Market Growth at 20.9% CAGR T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Ceramic Coated Separators Market Size Growth Forecast: What to Expect by 2025? The market size of ceramic coated separators has seen a remarkable increase in recent times, and it is set to expand from the value of $1.47 billion in 2024 to reach the value of $1.78 billion in

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the